Skip to content

Sustainable and Healthy Return-to-Work Program - PRATICAdr 2.0

Sustainable and Healthy Return-to-Work Program for Employees of Large Healthcare Organizations - PRATICAdr 2.0

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06397326
Acronym
PRATICAdr
Enrollment
49
Registered
2024-05-02
Start date
2024-05-06
Completion date
2026-04-15
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Mental Disorder

Keywords

Return to work, Sick leave duration, Relapses, Clinical symptoms

Brief summary

This study aims to assess the effectiveness of PRATICAdr 2.0, a web application facilitated by a Return-to-Work Coordinator (RTW-C), with a focus on reducing sick leave duration and preventing relapse in individuals with CMDs. PRATICAdr 2.0 designed to enhance collaboration among Return-to-Work (RTW) stakeholders and provide systematic support throughout the RTW process, is evaluated in a randomized control trial (RCT). As part of the RCT, a total of 80 sick leave employees from 4 large public health organizations (n=80, 40 from the experimental group and 40 from the control group) will be recruited. The control group receives usual services offered by a RTW-C to sick leave employees, while the experimental group receives RTW-C services plus the use of PRATICAdr 2.0.

Detailed description

Common mental disorders (CMDs) are highly prevalent in workplace settings, and have become a significant public health challenge. This study aims to assess the effectiveness of PRATICAdr 2.0, a web application facilitated by a Return-to-Work Coordinator (RTW-C), with a focus on reducing sick leave duration and preventing relapse in individuals with CMDs. PRATICAdr 2.0 designed to enhance collaboration among Return-to-Work (RTW) stakeholders and provide systematic support throughout the RTW process, is evaluated in a randomized control trial (RCT). As part of the RCT, a total of 80 sick leave employees from 4 large public health organizations (n=80, 40 from the experimental group and 40 from the control group) will be recruited. The control group receives usual services offered by a RTW-C to sick leave employees, while the experimental group receives RTW-C services plus the use of PRATICAdr 2.0. Participants will be randomly assigned to either the PRATICAdr 2.0 experimental group or the control group using computerized stratified randomization based on age, site, and sex (sealed envelope method). Participants will complete a series of online questionnaires at several following time points. Survival analyses were used to compare sick leave durations and relapses between the experimental group (PRATICAdr with RTW-C), and control groups (RTW-C only). Mixed linear models were used to observe changes in clinical symptoms over time, especially for the experimental group.

Interventions

BEHAVIORALReturn to work coordinator + PRATICAdr 2.0

The Return to work coordinator (RTW-C) uses PRATICAdr. 2.0 (web application).

BEHAVIORALReturn to work coordinator only

The Return to work coordinator (RTW-C) intervenes on employees on sick leave as usual

Sponsors

Université du Québec a Montréal
Lead SponsorOTHER
Centre intégré de santé et de services sociaux (CISSS) de la Gaspésie
CollaboratorUNKNOWN
Centre intégré de santé et de services sociaux (CISSS) de Laval
CollaboratorUNKNOWN
Centre hospitalier de l'Université de Montréal (CHUM)
CollaboratorOTHER
Centre intégré universitaire de santé et de services sociaux du Centre Ouest de Montréal
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Two groups: Experimental: Return to work coordinator + PRATICAdr 2.0 Control group: Return to work coordinator only

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Sick leave due to Common mental disorder (i.e. depression, anxiety, adjustment disorder, burnout) * Sick leave duration (from 1 to 3 months) * Member of participating unions in the large health organization

Exclusion criteria

* Inability to communicate in French * Have a known organic disorder * Have a professional dirsorder (CNESST) * Have experienced previous sick leaves due to Common mental disorder

Design outcomes

Primary

MeasureTime frameDescription
Sick leave durationthrough study completion, an average of 2 yearsThe number of days during the sick leave
Relapsesthrough study completion, an average of 2 yearsNumber of relapses after returning to work

Secondary

MeasureTime frameDescription
Depressive symptomsthrough study completion, an average of 2 yearsPatient Health Questionnaire for depression (PHQ-9; Kroenke et al., 2001)
Anxiety symptomsthrough study completion, an average of 2 yearsGeneralized Anxiety Disorder Scale (GAD-7; Spitzer et al., 2006)
Return to Work Obstacles and Self-Efficacythrough study completion, an average of 2 yearsReturn to Work Obstacles and Self-Efficacy Scale (ROSES ; Corbière et al., 2017 )

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026